Cell line · CVCL_1579
NCI-H69
Cancer cell line, Homo sapiens. Lung small cell carcinoma. 85 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H69. Cell lines, record CVCL_1579. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1579
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H69
- Accession
- CVCL_1579
- RRID
- RRID:CVCL_1579
- Synonyms
- NCI-H-69, NCI H69, H69, H-69, NCIH69, NCI-HUT-69, H69/P, NCI-H69C, H69C, H69c
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 55Y
- Category
- Cancer cell line
- Diseases
- Lung small cell carcinoma (NCIt C4917); Small cell lung cancer (ORDO Orphanet_70573)
- Derived from
- Pleural effusion (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers85
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Differential Sensitivity to xCT-inhibition by ME1 expression. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SCLC humanized mice identify T cell infiltration phenotypes in response to combination immune-radiation therapies. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KDM7B-mediated demethylation of RNF113A regulates small cell lung cancer sensitivity to alkylation damage. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In Vitro Anticancer Activity of Phytol on Human Non-Small Cell Lung Cancer A549 Cells. | Integr Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Jumonji histone demethylases are therapeutic targets in small cell lung cancer. | Oncogene | 2024 | Cellosaurus cites it | PubMed | |
| Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 85
See all 85 papersRelatives18
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | H69/BCNU | CVCL_0B21 | Cell lines | |
| Derived from it | H69/DAU | CVCL_0B22 | Cell lines | |
| Derived from it | H69/Txl | CVCL_X029 | Cell lines | |
| Derived from it | H69/VDS | CVCL_AZ78 | Cell lines | |
| Derived from it | H69/VP | CVCL_0B23 | Cell lines | |
| Derived from it | H69R | CVCL_RS65 | Cell lines | |
| Derived from it | H69V | CVCL_2466 | Cell lines | |
| Derived from it | H69VZ | CVCL_S830 | Cell lines | |
| Derived from it | NCI-H249 | CVCL_A537 | Has a recorded problem | Cell lines |
| Derived from it | NCI-H69/CPR | CVCL_2137 | Cell lines |
1 to 10 of 18
See all 18 relativesCell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-119 | ATCC | |
| CLS | 300185 | CLS | |
| ECACC | 91091802 | ECACC | |
| Hysigen | TCH-C609 | Hysigen | |
| IZSLER | BS TCL 172 | Cellosaurus | |
| KCLB | 30119 | KCLB | |
| NCI-DCTD | NCI-H69 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1579
GET https://conductscience.org/api/cell-lines/v1/CVCL_1579/papers?page=2